Share your thoughts, 1 month free Claude Pro on usSee more
WorkDL logo mark

Pathway-Structured Privileged Distillation for Deployable Computational Pathology

About

Integrating transcriptomics and histopathology can improve cancer risk modelling, yet practical use is constrained by the limited availability of RNA profiling in routine settings. Here we introduce Mixture of Pathway Experts (MoPE), a knowledge-distillation framework that reframes multimodal learning as privileged distillation for histology-only inference. MoPE is motivated by the partial observability between RNA profiles and whole-slide images: histology can capture morphology-linked consequences of certain molecular programmes, but cannot be expected to reconstruct the full transcriptomic state. MoPE encodes RNA-derived pathways and transfers the molecular supervision to pathway-indexed pathology experts through memory-usage alignment. Across diverse public benchmarks and two independent breast cancer cohorts, MoPE consistently improved WSI-only inference performance relative to baseline methods. Pathway-usage analyses and human-audited visual inspection provide bounded inspection of model behaviour and candidate morphology-linked readouts. These results support pathway-structured privileged distillation as a promising route to using molecular information during training while preserving RNA-free inference.

Yongxin Guo, Hao Lu, Onur Koyun, Muhammet Demir, Metin Gurcan• 2026

Related benchmarks

TaskDatasetResultRank
Survival PredictionTCGA-BRCA
C-index0.6918
149
Survival PredictionTCGA-STAD
C-index0.6127
125
Survival PredictionKIRC TCGA
C-Index0.7547
102
Survival AnalysisTCGA-GBMLGG
C-index0.8465
73
PR status classificationTCGA-BRCA
AUC0.8827
27
Clinical ClassificationLUAD-EGFR
AUC75.9
18
Clinical ClassificationBRCA-ODX
AUC85.38
18
Clinical ClassificationLUAD-Hypoxia
AUC82.17
18
Clinical ClassificationGBMLGG Mesenchymal
AUC80.09
18
Clinical ClassificationExt-ODX
AUC79.88
12
Showing 10 of 10 rows

Other info

Follow for update